Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-01 Sale | 2024-11-05 12:06 pm | ESSA Pharma Inc. | EPIX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner | 7,879,583 | $1.5253 | $12,018,409 | 0 (Direct) | View |
| 2023-10-17 Purchase | 2023-10-19 3:08 pm | Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner | 400,000 | $2.3352 | $934,080 | 8,517,839 (Direct) | View |
| 2023-06-30 Purchase | 2023-07-03 3:36 pm | Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner | 1,000,000 | $5 | $5,000,000 | 8,117,839 (Direct) | View |
| 2023-06-27 Purchase | 2023-06-29 1:37 pm | Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner | 1,740,000 | $5.4914 | $9,555,036 | 7,117,839 (Direct) | View |
| 2022-10-31 Purchase | 2022-11-02 3:10 pm | Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner | 99,801 | $2.2536 | $224,912 | 5,377,839 (Direct) | View |
| 2022-10-27 Purchase | 2022-10-31 3:20 pm | Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner | 364,652 | $2.0189 | $736,186 | 5,278,038 (Direct) | View |
| 2022-10-26 Purchase | 2022-10-28 2:57 pm | ESSA Pharma Inc. | EPIX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner | 2,000,000 | $4.1098 | $8,219,600 | 7,879,583 (Direct) | View |
| 2022-10-21 Purchase | 2022-10-25 4:24 pm | Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner | 87,850 | $1.5111 | $132,750 | 4,913,386 (Direct) | View |
| 2022-10-19 Purchase | 2022-10-21 3:06 pm | Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner | 131,423 | $1.3629 | $179,120 | 4,825,536 (Direct) | View |
| 2022-07-18 Purchase | 2022-07-20 3:21 pm | ESSA Pharma Inc. | EPIX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner | 300,000 | $3.1558 | $946,740 | 5,879,583 (Direct) | View |
| 2022-07-14 Purchase | 2022-07-18 12:48 pm | ESSA Pharma Inc. | EPIX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner | 588,869 | $2.9314 | $1,726,226 | 5,579,583 (Direct) | View |
| 2022-04-27 Purchase | 2022-04-29 10:50 am | Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner | 405,711 | $2.6062 | $1,057,348 | 4,694,113 (Direct) | View |
| 2022-04-27 Sale | 2022-04-28 12:28 pm | ESSA Pharma Inc. | EPIX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner | 25,100 | $5.8536 | $146,925 | 4,990,714 (Direct) | View |
| 2022-04-18 Purchase | 2022-04-20 12:56 pm | Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner | 300,000 | $3.2686 | $980,580 | 4,288,402 (Direct) | View |
| 2022-04-12 Purchase | 2022-04-14 12:09 pm | Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner | 252,556 | $3.4837 | $879,817 | 3,988,402 (Direct) | View |
| 2021-08-18 Purchase | 2021-08-20 12:43 pm | ESSA Pharma Inc. | EPIX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner | 250,000 | $8.8752 | $2,218,800 | 5,015,814 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2022-04-13 4:22 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner | 0 | $0 | 3,735,846 (Direct) | View |
Ownership | 2021-08-17 2:07 pm | N/A N/A | ESSA Pharma Inc. | EPIX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner | 0 | $0 | 4,765,814 (Direct) | View |